Stephen Machatha
Chief Development Officer, Aldeyra Therapeutics, Inc.
Companies
- Aldeyra Therapeutics, Inc.Chief Development Officer Dec 18, 2020 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aldeyra Therapeutics, Inc. ALDX222,010 shares2$168.9K at $0.76Aug 11, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 11, 2025Sold 22,073 shares at $5.15 of Aldeyra Therapeutics, Inc.2
- Aug 12, 2024Sold 16,041 shares at $4.74 of Aldeyra Therapeutics, Inc.3
- Mar 12, 2024Sold 11,537 shares at $3.16 of Aldeyra Therapeutics, Inc.4
- Mar 12, 2024Sold 11,537 shares at $3.16 of Aldeyra Therapeutics, Inc.5
- Mar 11, 2024Sold 18,231 shares at $3.41 of Aldeyra Therapeutics, Inc.4
- Jul 15, 2022Granted 185,605 shares of Aldeyra Therapeutics, Inc.6
- Mar 30, 2022Granted 64,395 shares of Aldeyra Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Aug 14, 2024
- 4SEC EDGARForm 4 filed Mar 12, 2024
- 5SEC EDGARForm 4 filed Apr 17, 2024
- 6SEC EDGARForm 4 filed Jul 19, 2022
- 7SEC EDGARForm 4 filed Apr 1, 2022